Thursday, 30 June 2016


Gayatri Projects soared 3.5% to Rs.644. The company has bagged a Rs.306 crore contract for the four laning of a highway on the Andhra Pradesh-Tamil Nadu border from the Ministry of Road Transport & Highways (NHDP-IVA Cell).

The scrip opened at Rs. 625.45 and has touched a high and low of Rs. 645 and Rs. 622.05 respectively. So far 7449(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 2206.08 crore.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 769.2 on 24-Dec-2015 and a 52 week low of Rs. 260.8 on 30-Jun-2015. Last one week high and low of the scrip stood at Rs. 640 and Rs. 557 respectively. The promoters holding in the company stood at 47.48 % while Institutions and Non-Institutions held 41.35 % and 11.17 % respectively.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

Zensar Technologies announced the successful reimplementation of the new Oracle E­ Business Suite Release 12 for the Unicomer Group, a large multinational retailer in Latin America, headquartered in El Salvador. Unicomer's key business objective of this implementation was aimed at streamlining key financial and business processes for greater efficiencies.

"The successful implementation at Unicomer underlines our Oracle expertise and offering. The deep technology expertise coupled with our retail domain exper ience point to the understanding we have of our customers' challenges and our readiness to help them achieve critical business transformation;efficiently and seamless ly. Our delivery excellence helps us achieve significant business outcomes for our customers, each time," commented Sandeep Kishore, CEO and Managing Director, Zensar Technologies.

Peter Klingeman, Chief Financial Officer, Unicomer Group said,"We have an expansionary vision that fuels the need to make operations simple and profitable. Technology plays a critical role in helping us make a successful transformation. The Zensar team understood our model and helped us implement Oracle within the desired timeline,making it possible for us to move closer to achieving our business objectives and vision."

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

At its meeting held on June 29, 2016, the board of directors of IDBI Bank Ltd have approved the appointment of R. K. Bansal, Executive Director as CFO and Key Managerial Personnel of IDBI Bank w.e.f July 01, 2016, the bank said today.

The new appointment has come in place of N. S. Venkatesh, Executive Director & CFO, who demits office on June 30, 2016 (c.o.b). R. K. Bansal is a qualified Chartered Accountant and has approximately 32 years of experience in IDBI Bank in different grades.

IDBI Bank Ltd is currently trading at Rs. 70.2, up by Rs. 1.1 or 1.59% from its previous closing of Rs. 69.1 on the BSE. The scrip opened at Rs. 69.7 and has touched a high and low of Rs. 70.4 and Rs. 69.45 respectively. So far 1754691(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 14226.41 crore.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 95.7 on 03-Dec-2015 and a 52 week low of Rs. 47.4 on 12-Feb-2016. Last one week high and low of the scrip stood at Rs. 70.3 and Rs. 63.35 respectively. The promoters holding in the company stood at 73.98 % while Institutions and Non-Institutions held 18.61 % and 7.41 % respectively. The stock is currently trading above its 200 DMA.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717


Alembic Pharmaceuticals Ltd has informed BSE that the company's API facilities i.e. API I and API II, both located at Panelav, have been successfully inspected by the USFDA between June 20, 2016 and June 29, 2016. The company did not receive any Form 483 observations.

Alembic Pharmaceuticals Ltd is currently trading at Rs. 579, up by Rs. 32.05 or 5.86% from its previous closing of Rs. 546.95 on the BSE. The scrip opened at Rs. 547.35 and has touched a high and low of Rs. 595 and Rs. 547.35 respectively. So far 677638(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 10310.01 crore.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 791.7 on 15-Jul-2015 and a 52 week low of Rs. 514.35 on 05-Feb-2016. Last one week high and low of the scrip stood at Rs. 555.6 and Rs. 517.9 respectively. The promoters holding in the company stood at 74.13 % while Institutions and Non-Institutions held 12.92 % and 12.96 % respectively. The stock is currently trading above its 200 DMA.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

Binani Industries dropped 3.2% to Rs.84.10 after the Bombay High Court in an order asked secured creditors of its subsidiary Edayar Zinc to seek symbolic possession of immovable property. The scrip opened at Rs. 85.7 and has touched a high and low of Rs. 86.85 and Rs. 82.6 respectively. So far 265240(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 272.42 crore.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 101.3 on 14-Jul-2015 and a 52 week low of Rs. 50 on 12-Feb-2016. Last one week high and low of the scrip stood at Rs. 94.8 and Rs. 65.45 respectively.

The promoters holding in the company stood at 52.62 % while Institutions and Non-Institutions held 2.56 % and 44.83 % respectively.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

State Bank of India stock was up by 2% at Rs. 221. The company is planning to raise long term funds up to US$1,500 million (US$ one thousand five hundred million) in single / multiple tranches through a public offer and/or private placement of senior unsecured notes in US Dollar or any other convertible currency during the Financial year 2016-17.

The scrip opened at Rs. 220 and has touched a high and low of Rs. 221.8 and Rs. 219.35 respectively. So far 7472688(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 168607.52 crore.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 291.85 on 05-Aug-2015 and a 52 week low of Rs. 148.3 on 12-Feb-2016. Last one week high and low of the scrip stood at Rs. 218.7 and Rs. 202.55 respectively.

The promoters holding in the company stood at 60.18 % while Institutions and Non-Institutions held 27.88 % and 10.07 % respectively. The stock is currently trading above its 200 DMA.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

Drug firm Suven Life Sciences said that it has been granted a patent from Europe and two product patents from Eurasia for a drug used in the treatment of neuro-degenerative diseases. (FC)

RPG Life Sciences has announced its foray into the cosmetics business with the tie-up with Italy-Swiss based Labo Cosprophar. The company will market hair-growth product Crescina and a wrinkle-free and anti-ageing skin care product called Fillerina. Speaking to Bloomberg TV India, RPG MD CT Renganathan says the company aims to grab a 10 per cent market share in the Rs.250-crore cosmetic dermatology segment. The company also aims to increase its turnover to Rs1,000 crore through new product launches, licensing pacts and geographic expansion, he said. The company is now focusing more on Europe and emerging markets. RPG also aims to get into the US market by 2019. (HBL)

Sun Pharma announced buyback of 15 million shares at a price of Rs 900 per share through the tender route with the promoters indicating their intention to participate in the buyback. The buyback is valued at Rs 6.75 billion ($100 million). This combination of promoter participation in the buyback and the small size of the buyback itself makes us believe that it is being used as an alternate tax-efficient distribution tool, and is not triggered by “attractive valuations”. Given our view on valuations, we would have been worried had SUNP announced a large buyback (over and above the dividend). (FC)

Fortis Hospital, Bannerghatta which has continuously strived hard to provide quality care has adorned another feather in its cap by bagging the “Best Medical Tourism Hospital” award in recently concluded “The Karnataka tourism awards – 2016 organized by Federation of Karnataka Chambers of Commerce and Industry (FKCCI) on 27 June 2016 at Hotel Lalit Ashok.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

GATI Kausar, the subsidiary of Gati, is launching a temperature-controlled warehousing facility near Delhi, the company said. The 5,000-pallet capacity unit is spread over four acres. 

The scrip opened at Rs. 173.9 and has touched a high and low of Rs. 174.45 and Rs. 172.4 respectively. So far 626350(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 1517.14 crore.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 206.5 on 30-Jul-2015 and a 52 week low of Rs. 94.6 on 12-Feb-2016. Last one week high and low of the scrip stood at Rs. 175 and Rs. 145.75 respectively.

The promoters holding in the company stood at 41.04 % while Institutions and Non-Institutions held 13.56 % and 45.4 % respectively. The stock is currently trading above its 200 DMA.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717


With reference to the earlier announcements dated April 12, 2016 and June 28, 2016 in relation to the proposed Initial Public Offering of Equity Shares of the Company's Subsidiary, L&T Infotech, Larsen & Toubro Ltd has announced that the Price Band has been fixed between Rs. 705 to Rs. 710 per equity share. A discount of Rs. 10 per equity share will be offered to retail individual bidders.

The scrip opened at Rs. 1490 and has touched a high and low of Rs. 1497.7 and Rs. 1486.05 respectively. So far 182344(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 138104.94 crore.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1886.25 on 17-Jul-2015 and a 52 week low of Rs. 1016.6 on 12-Feb-2016. Last one week high and low of the scrip stood at Rs. 1506 and Rs. 1401.4 respectively. The promoters holding in the company stood at 0 % while Institutions and Non-Institutions held 54.51 % and 43.43 % respectively. The stock is currently trading above its 50 DMA.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

Wednesday, 29 June 2016


Bharti Airtel, India’s largest telecommunications services provider, has adopted Cloudera Enterprise to build a 360-degree view of their customers in India, enabling them to better leverage customer data to execute successful omni-channel campaigns and influence buyers in a highly competitive market.

Communications service providers (CSPs) are amongst the world’s biggest aggregators of consumer information and have to keep pace in order to gain insights into their customers’ preferences and networks. Many CSPs, like Airtel, are utilizing Cloudera Enterprise to securely bring together user, network, device, business and social data to drive customer intimacy, improve network performance and drive new revenue streams.

Airtel's product offerings in India include wireless and fixed services, mobile commerce, high speed DSL broadband, IPTV, DTH, and national and international long distance services to carriers. With over 265 million customers across its India operations, Airtel faces the immense task of making sense of and leveraging huge volumes of customer and network data they collect on a daily basis, which was previously stored in multiple traditional systems built over a period of time.

“As part of our digital journey at Airtel, our main focus is on providing the best customer experience with our new Business Intelligence (BI) and analytics platform, powered by Cloudera. Now, we are able to gain an even greater technical edge, empowering our marketers with intelligent data and analytics to make better decisions and improve the entire customer lifecycle with customized offerings.” said Harmeen Mehta, Group CIO for Bharti Airtel Limited.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

Premier Explosives Ltd has has received on June 28, 2016, Industrial License vide License dated June 17, 2016, from the Department of Industrial Policy and Promotion (DIPP), for Site Mixed Explosives' at Mellacheruvu Mandal, Dondapadu Village, Nalgonda District, in the state of Telangana.

Premier Explosives Ltd is currently trading at Rs. 370, up by Rs. 17.1 or 4.85% from its previous closing of Rs. 352.9 on the BSE. The scrip opened at Rs. 353.05 and has touched a high and low of Rs. 385 and Rs. 347 respectively. So far 81940(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 312.62 crore.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 519 on 07-Jan-2016 and a 52 week low of Rs. 261.5 on 29-Jun-2015. Last one week high and low of the scrip stood at Rs. 372.9 and Rs. 336.1 respectively. The promoters holding in the company stood at 47.45 % while Institutions and Non-Institutions held 6.18 % and 46.38 % respectively. The stock is currently trading above its 50 DMA.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717